ENZC Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED
Enzolytics Inc

Enzolytics Inc. Stock Analysis ENZC

United States Health Care Nano Cap Report:
Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company is headquartered in Monrovia California, California. The company went IPO on 2008-12-29. The firm is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases to include the additional contracted areas of sales, marketing and distribution of medical devices, medical testing and nutraceutical products. Its subsidiaries include BioClonetics lmmunotherapy, Inc. and Biogenysis, Inc.
Read More

Enzolytics Inc (ENZC) Chart

Key Statistics of Enzolytics Inc (ENZC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

1.83M

P/E Ratio (TTM)

-

52 Week Range

$0.00$0.00

Market Cap

2.37M

Avg. Volume

3.12M

Dividend Yield

-

Financial Metrics & Statements of Enzolytics Inc (ENZC)

  • Per Share Data
  • Ratios
  • Statements
No data

No Data Available!

  • Annual Icon Annual
  • Quarterly Icon Quarterly
No data

No Annual Data Available!

FAQ's for Enzolytics Inc (ENZC)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.